Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has been assigned a consensus rating of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have covered the stock […]